Risk Factors for Multidrug Resistance in Patients Infected with Carbapenem-Resistant Klebsiella pneumoniae: A Nomogram.

IF 2.9 3区 医学 Q2 INFECTIOUS DISEASES
Infection and Drug Resistance Pub Date : 2024-11-03 eCollection Date: 2024-01-01 DOI:10.2147/IDR.S479374
Yaning Gao, Liang Chen, Zhengjun Wen, Huiying Jiang, Jing Feng
{"title":"Risk Factors for Multidrug Resistance in Patients Infected with Carbapenem-Resistant <i>Klebsiella pneumoniae</i>: A Nomogram.","authors":"Yaning Gao, Liang Chen, Zhengjun Wen, Huiying Jiang, Jing Feng","doi":"10.2147/IDR.S479374","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Our aim was to determine the risk factors for multidrug resistance in patients with carbapenem-resistant <i>Klebsiella pneumoniae</i> (CRKP).</p><p><strong>Methods: </strong>The information of 196 patients with <i>Klebsiella pneumoniae</i> infection was collected. The patients were subsequently assigned to the carbapenem-resistant, multidrug-resistant, and non-multidrug-resistant groups. The risk factors for multidrug resistance in CRKP patients were assessed via least absolute shrinkage and selection operator and logistic regression analyses. Moreover, a nomogram was constructed dependent on the identified risk factors, and calibration and decision curves were plotted to detect its accuracy.</p><p><strong>Results: </strong>Length of stay (LOS) [odds ratio (OR) and 95% confidence interval (CI): 4.558 (1.157-17.961), P = 0.030], intensive care unit (ICU) stay within 30 days [OR and 95% CI: 12.643 (3.780-42.293), P < 0.001], Glasgow Coma Scale (GCS) score [OR and 95% CI: 13.569 (2.738-67.236), P = 0.001], fungal infection [OR and 95% CI: 6.398 (1.969-20.785), P = 0.002], and cardiovascular disease (CVD) [OR and 95% CI: 3.871 (1.293-11.592), P = 0.016] were identified as risk factors for multidrug resistance in CRKP patients. The concordance index (C-index) of the constructed nomogram was 0.950 (95% CI: 0.945-0.955). Moreover, decision curve analysis elucidated the nomogram utilization across a wide range of probability thresholds, ranging from 1% to 100%. Finally, internal validation using random data validated the robustness of the predictive model, yielding a C-index of 0.937.</p><p><strong>Conclusion: </strong>The LOS, ICU stay within 30 days, GCS score, fungal infection, and CVD were recognized as risk factors for multidrug resistance in CRKP patients. The constructed nomogram could accurately predict multidrug-resistant CRKP infections in patients.</p>","PeriodicalId":13577,"journal":{"name":"Infection and Drug Resistance","volume":"17 ","pages":"4833-4841"},"PeriodicalIF":2.9000,"publicationDate":"2024-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11534326/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infection and Drug Resistance","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/IDR.S479374","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Our aim was to determine the risk factors for multidrug resistance in patients with carbapenem-resistant Klebsiella pneumoniae (CRKP).

Methods: The information of 196 patients with Klebsiella pneumoniae infection was collected. The patients were subsequently assigned to the carbapenem-resistant, multidrug-resistant, and non-multidrug-resistant groups. The risk factors for multidrug resistance in CRKP patients were assessed via least absolute shrinkage and selection operator and logistic regression analyses. Moreover, a nomogram was constructed dependent on the identified risk factors, and calibration and decision curves were plotted to detect its accuracy.

Results: Length of stay (LOS) [odds ratio (OR) and 95% confidence interval (CI): 4.558 (1.157-17.961), P = 0.030], intensive care unit (ICU) stay within 30 days [OR and 95% CI: 12.643 (3.780-42.293), P < 0.001], Glasgow Coma Scale (GCS) score [OR and 95% CI: 13.569 (2.738-67.236), P = 0.001], fungal infection [OR and 95% CI: 6.398 (1.969-20.785), P = 0.002], and cardiovascular disease (CVD) [OR and 95% CI: 3.871 (1.293-11.592), P = 0.016] were identified as risk factors for multidrug resistance in CRKP patients. The concordance index (C-index) of the constructed nomogram was 0.950 (95% CI: 0.945-0.955). Moreover, decision curve analysis elucidated the nomogram utilization across a wide range of probability thresholds, ranging from 1% to 100%. Finally, internal validation using random data validated the robustness of the predictive model, yielding a C-index of 0.937.

Conclusion: The LOS, ICU stay within 30 days, GCS score, fungal infection, and CVD were recognized as risk factors for multidrug resistance in CRKP patients. The constructed nomogram could accurately predict multidrug-resistant CRKP infections in patients.

耐碳青霉烯类抗生素肺炎克雷伯氏菌感染患者耐多药的风险因素:示意图。
目的:我们的目的是确定耐碳青霉烯类肺炎克雷伯菌(CRKP)患者耐多药的风险因素:收集了 196 名肺炎克雷伯菌感染患者的信息。方法:收集了 196 名肺炎克雷伯菌感染患者的信息,随后将患者分为耐碳青霉烯类、耐多药和非耐多药三组。通过最小绝对缩减和选择算子以及逻辑回归分析,评估了 CRKP 患者耐多药的风险因素。此外,还根据确定的风险因素构建了一个提名图,并绘制了校准和决策曲线以检测其准确性:住院时间(LOS)[几率比(OR)和 95% 置信区间(CI):4.558(1.157-17.961),P = 0.030]、重症监护室(ICU)30 天内住院时间[OR 和 95% CI:12.643(3.780-42.293),P <0.001]、格拉斯哥昏迷量表(GCS)评分[OR 和 95% CI:13.569(2.738-67.236),P = 0.001]、真菌感染[OR 和 95% CI:6.398(1.969-20.785),P = 0.002]以及心血管疾病(CVD)[OR 和 95% CI:3.871(1.293-11.592),P = 0.016]被确定为 CRKP 患者多重耐药的危险因素。构建的提名图的一致性指数(C-index)为 0.950(95% CI:0.945-0.955)。此外,决策曲线分析还阐明了提名图在从 1%到 100%的各种概率阈值范围内的利用率。最后,使用随机数据进行的内部验证验证了预测模型的稳健性,得出的 C 指数为 0.937:LOS、30 天内入住 ICU、GCS 评分、真菌感染和心血管疾病被认为是 CRKP 患者耐多药的风险因素。所构建的提名图能准确预测 CRKP 患者的耐多药感染。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Infection and Drug Resistance
Infection and Drug Resistance Medicine-Pharmacology (medical)
CiteScore
5.60
自引率
7.70%
发文量
826
审稿时长
16 weeks
期刊介绍: About Journal Editors Peer Reviewers Articles Article Publishing Charges Aims and Scope Call For Papers ISSN: 1178-6973 Editor-in-Chief: Professor Suresh Antony An international, peer-reviewed, open access journal that focuses on the optimal treatment of infection (bacterial, fungal and viral) and the development and institution of preventative strategies to minimize the development and spread of resistance.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信